These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15274875)

  • 1. [Prenatal corticosteroid and early surfactant therapy in infants born at < or = 30 weeks gestation].
    Valls i Soler A; Páramo Andrés S; Fernández-Ruanova B;
    An Pediatr (Barc); 2004 Aug; 61(2):118-23. PubMed ID: 15274875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation.
    Silver RK; Vyskocil C; Solomon SL; Ragin A; Neerhof MG; Farrell EE
    Obstet Gynecol; 1996 May; 87(5 Pt 1):683-91. PubMed ID: 8677067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.
    Kari MA; Hallman M; Eronen M; Teramo K; Virtanen M; Koivisto M; Ikonen RS
    Pediatrics; 1994 May; 93(5):730-6. PubMed ID: 8165070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early outcome of extremely low birth weight infants in Taiwan.
    Tsao PN; Teng RJ; Wu TJ; Tang JR; Yau KI
    J Formos Med Assoc; 1998 Jul; 97(7):471-6. PubMed ID: 9700244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal complications after the administration of indomethacin for preterm labor.
    Norton ME; Merrill J; Cooper BA; Kuller JA; Clyman RI
    N Engl J Med; 1993 Nov; 329(22):1602-7. PubMed ID: 8232428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 weeks of gestation.
    Mori R; Kusuda S; Fujimura M;
    J Pediatr; 2011 Jul; 159(1):110-114.e1. PubMed ID: 21334006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal corticosteroid therapy in premature infants.
    Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M
    Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe pulmonary hemorrhage in the premature newborn infant: analysis of presurfactant and surfactant eras.
    Braun KR; Davidson KM; Henry M; Nielsen HC
    Biol Neonate; 1999; 75(1):18-30. PubMed ID: 9831680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
    Modanlou HD; Beharry K; Padilla G; Iriye B
    J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory distress syndrome in VLBW infants: changes in management and outcomes observed by the NICHD Neonatal Research Network.
    St John EB; Carlo WA
    Semin Perinatol; 2003 Aug; 27(4):288-92. PubMed ID: 14510319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2000; (2):CD000510. PubMed ID: 10796379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants.
    Farrell EE; Silver RK; Kimberlin LV; Wolf ES; Dusik JM
    Am J Obstet Gynecol; 1989 Sep; 161(3):628-33. PubMed ID: 2675599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: is routine practice evidence based?
    Horbar JD; Carpenter JH; Buzas J; Soll RF; Suresh G; Bracken MB; Leviton LC; Plsek PE; Sinclair JC;
    Pediatrics; 2004 Jun; 113(6):1593-602. PubMed ID: 15173479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.